HU177578B - Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives - Google Patents

Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives Download PDF

Info

Publication number
HU177578B
HU177578B HU76CI1682A HUCI001682A HU177578B HU 177578 B HU177578 B HU 177578B HU 76CI1682 A HU76CI1682 A HU 76CI1682A HU CI001682 A HUCI001682 A HU CI001682A HU 177578 B HU177578 B HU 177578B
Authority
HU
Hungary
Prior art keywords
formula
amidoxime
defined above
hydrogen
phenyl
Prior art date
Application number
HU76CI1682A
Other languages
English (en)
Hungarian (hu)
Inventor
Kalman Takacs
Nagy Peter Literati
Ajzert Ilona Kissne
Antal Simay
Matyas Szentivanyi
Sandor Viragh
Imrene Farago
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Priority to HU76CI1682A priority Critical patent/HU177578B/hu
Priority to AT874178A priority patent/AT361457B/de
Priority to AT605477A priority patent/AT355554B/de
Priority to SE7709482A priority patent/SE435280B/xx
Priority to NLAANVRAGE7709276,A priority patent/NL187478C/xx
Priority to IL7752804A priority patent/IL52804A/xx
Priority to CS775551A priority patent/CS204008B2/cs
Priority to DD7700200719A priority patent/DD132433A5/xx
Priority to GR54222A priority patent/GR63623B/el
Priority to YU02023/77A priority patent/YU202377A/xx
Priority to GB35745/77A priority patent/GB1582029A/en
Priority to FI772551A priority patent/FI68396C/fi
Priority to AU28254/77A priority patent/AU521432B2/en
Priority to FR7726070A priority patent/FR2362845A1/fr
Priority to PL20048077A priority patent/PL106317B1/pl
Priority to BE180447A priority patent/BE858134A/xx
Priority to CA285,529A priority patent/CA1077506A/en
Priority to PL1977206476A priority patent/PL107628B1/pl
Priority to DE19772738589 priority patent/DE2738589A1/de
Priority to SU772514754A priority patent/SU730296A3/ru
Priority to CH1047377A priority patent/CH630344A5/de
Priority to NO772958A priority patent/NO144793C/no
Priority to JP10250477A priority patent/JPS5350131A/ja
Priority to DK379777A priority patent/DK150196C/da
Priority to ES77462346A priority patent/ES462346A1/es
Priority to CS785952A priority patent/CS204009B2/cs
Publication of HU177578B publication Critical patent/HU177578B/hu
Priority to YU02377/82A priority patent/YU237782A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/14—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
HU76CI1682A 1976-08-27 1976-08-27 Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives HU177578B (en)

Priority Applications (27)

Application Number Priority Date Filing Date Title
HU76CI1682A HU177578B (en) 1976-08-27 1976-08-27 Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives
AT874178A AT361457B (de) 1976-08-27 1977-08-22 Verfahren zur herstellung von neuen o-(3-amino- -2-hydroxypropyl)-amidoxim-derivaten und deren saeureadditionssalzen
AT605477A AT355554B (de) 1976-08-27 1977-08-22 Verfahren zur herstellung von neuen o-(3-amino- 2-hydroxypropyl)-amidoxim-derivaten, deren saeureadditionssalzen und deren optisch aktiven antipoden
SE7709482A SE435280B (sv) 1976-08-27 1977-08-23 Sett att framstella nya 0-(3-amino-2-hydroxipropyl)-amidoximderivat
NLAANVRAGE7709276,A NL187478C (nl) 1976-08-27 1977-08-23 Werkwijze voor het bereiden van amidoximderivaten, alsmede werkwijze ter bereiding van een geneesmiddel.
IL7752804A IL52804A (en) 1976-08-27 1977-08-23 O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives,their preparation and pharmaceutical compositions containing them
CS775551A CS204008B2 (en) 1976-08-27 1977-08-24 Process for preparing new derivatives of 0-/3-amino-2-hydroxypropyl/-amidoxime
DD7700200719A DD132433A5 (de) 1976-08-27 1977-08-24 Verfahren zur herstellung neuer 0-(3-amino-2-hydroxypropyl)-amidoxim-derivate
GR54222A GR63623B (en) 1976-08-27 1977-08-24 Process for the preparation of new o-/3-amino-2-hydroxyl-propyl/-amidoxime derivatives
YU02023/77A YU202377A (en) 1976-08-27 1977-08-25 Process for obtaining o-(3-amino-2-hydroxypropyl)-amidoximes
GB35745/77A GB1582029A (en) 1976-08-27 1977-08-25 Amidoxime derivatives
FR7726070A FR2362845A1 (fr) 1976-08-27 1977-08-26 Nouveaux derives de o-(3-amino-2-hydroxy-propyl)-amidoxime, procede pour leur preparation et compositions pharmaceutiques les contenant
CH1047377A CH630344A5 (en) 1976-08-27 1977-08-26 Process for the preparation of novel O-(3-amino-2-hydroxypropyl)-amidoxime derivatives.
FI772551A FI68396C (fi) 1976-08-27 1977-08-26 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 0-(3-amino-2-hydroxi-propyl)-amidoximderivat
PL20048077A PL106317B1 (pl) 1976-08-27 1977-08-26 Sposob wytwarzania nowych pochodnych 0-/3-amino-2-hydroksypropylo/-amidoksymu
BE180447A BE858134A (fr) 1976-08-27 1977-08-26 Nouveaux derives de 0-(3-amino-2-hydroxy-propyl)-amidoxime, procede pour leur preparation et compositions pharmaceutiques
CA285,529A CA1077506A (en) 1976-08-27 1977-08-26 O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions comprising the same
PL1977206476A PL107628B1 (pl) 1976-08-27 1977-08-26 Sposob wytwarzania nowych pochodnych o-/3-amino-2-hydroksypropylo/-amidoksymu
DE19772738589 DE2738589A1 (de) 1976-08-27 1977-08-26 Neue 0-(3-amino-2-hydroxypropyl)- amidoxim-derivate, ihr herstellungsverfahren und pharmazeutische mittel
SU772514754A SU730296A3 (ru) 1976-08-27 1977-08-26 Способ получени производных 0-(з-амино2-оксипропил)-амидоксима или их солей
AU28254/77A AU521432B2 (en) 1976-08-27 1977-08-26 0-(3-amino-2-hydroxy - propyl) - amidoxine derivatives
NO772958A NO144793C (no) 1976-08-27 1977-08-26 Analogifremgangsmaate ved fremstilling av o-(3-amino-2-hydroxypropyl)-amidoximderivater
JP10250477A JPS5350131A (en) 1976-08-27 1977-08-26 Production of novel amidoxime derivatives and pharmaceutical composition
DK379777A DK150196C (da) 1976-08-27 1977-08-26 Analogifremgangsmaade til fremstilling af 0-(3-amino-2-hydroxypropyl)-amidoximderivater eller farmaceutisk acceptable salte deraf
ES77462346A ES462346A1 (es) 1976-08-27 1977-09-08 Procedimiento para preparar derivados de amidoxima.
CS785952A CS204009B2 (cs) 1976-08-27 1978-09-14 Způsob výroby nových derivátů O-(3-amino-2-hydroxypropyl)amidoximu
YU02377/82A YU237782A (en) 1976-08-27 1982-10-22 Process for obtaining new o-(3-amino-2-hydroxy-propyl)-amidoxime derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU76CI1682A HU177578B (en) 1976-08-27 1976-08-27 Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives

Publications (1)

Publication Number Publication Date
HU177578B true HU177578B (en) 1981-11-28

Family

ID=10994625

Family Applications (1)

Application Number Title Priority Date Filing Date
HU76CI1682A HU177578B (en) 1976-08-27 1976-08-27 Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives

Country Status (23)

Country Link
JP (1) JPS5350131A (en, 2012)
AT (1) AT355554B (en, 2012)
AU (1) AU521432B2 (en, 2012)
BE (1) BE858134A (en, 2012)
CA (1) CA1077506A (en, 2012)
CH (1) CH630344A5 (en, 2012)
CS (1) CS204008B2 (en, 2012)
DD (1) DD132433A5 (en, 2012)
DE (1) DE2738589A1 (en, 2012)
DK (1) DK150196C (en, 2012)
ES (1) ES462346A1 (en, 2012)
FI (1) FI68396C (en, 2012)
FR (1) FR2362845A1 (en, 2012)
GB (1) GB1582029A (en, 2012)
GR (1) GR63623B (en, 2012)
HU (1) HU177578B (en, 2012)
IL (1) IL52804A (en, 2012)
NL (1) NL187478C (en, 2012)
NO (1) NO144793C (en, 2012)
PL (1) PL107628B1 (en, 2012)
SE (1) SE435280B (en, 2012)
SU (1) SU730296A3 (en, 2012)
YU (2) YU202377A (en, 2012)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849522A (en) * 1983-11-03 1989-07-18 Merrell Dow Pharmaceuticals Novel alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
ZA848428B (en) * 1983-11-03 1985-06-26 Merrell Pharma Inc Novel alkoxyimino ether derivatives of 5-acyl-2(1h)-pyridiones
US5212314A (en) * 1983-11-03 1993-05-18 Merrell Dow Pharmaceuticals Inc. Alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
JPH01169445A (ja) * 1987-12-25 1989-07-04 Fuji Photo Film Co Ltd 焦点距離切換えカメラ
HU207988B (en) * 1988-10-20 1993-07-28 Biorex Kutato Fejlesztoe Kft Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
HUT54347A (en) * 1989-01-10 1991-02-28 Chinoin Gyogyszer Es Vegyeszet Improved process for producing amidoximes
HU222994B1 (hu) 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
HUT78139A (hu) * 1995-12-22 2000-11-28 BIOREX Kutató és Fejlesztő Rt. Készítmény, különösen a bőr öregedési folyamatainak mérséklésére
HUP9602204D0 (en) * 1996-08-09 1996-10-28 Biorex Rt Pharmaceutical compositions for treating diseases connected with the disfunction of the vascular endothelial cells
WO1999058510A1 (en) 1998-05-11 1999-11-18 Takeda Chemical Industries, Ltd. Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity
WO2000007580A2 (en) * 1998-08-03 2000-02-17 N-Gene Kutató Kft. Pharmaceutical compositions against autoimmune diseases
EP1492763A1 (en) 2002-01-11 2005-01-05 Biorex Kutato Es Fejlesztö Rt. Carboxamidine derivatives and their use in the treatment of vascular diseases
HUP0303584A3 (en) 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
JP2024500632A (ja) 2020-11-19 2024-01-10 ゼブラ デンマーク エー／エス アリモクロモルクエン酸塩及びその中間体の調製プロセス

Also Published As

Publication number Publication date
IL52804A0 (en) 1977-10-31
PL107628B1 (pl) 1980-02-29
NO772958L (no) 1978-02-28
GR63623B (en) 1979-11-27
YU202377A (en) 1983-12-31
SU730296A3 (ru) 1980-04-25
ES462346A1 (es) 1978-06-16
CH630344A5 (en) 1982-06-15
JPS6216942B2 (en, 2012) 1987-04-15
DK379777A (da) 1978-02-28
NL7709276A (nl) 1978-03-01
NL187478C (nl) 1991-10-16
YU237782A (en) 1983-12-31
IL52804A (en) 1981-06-29
GB1582029A (en) 1980-12-31
AU2825477A (en) 1979-03-01
ATA605477A (de) 1979-08-15
AU521432B2 (en) 1982-04-01
FR2362845B1 (en, 2012) 1981-01-09
FI68396B (fi) 1985-05-31
CS204008B2 (en) 1981-03-31
SE7709482L (sv) 1978-02-28
FR2362845A1 (fr) 1978-03-24
NO144793B (no) 1981-08-03
SE435280B (sv) 1984-09-17
AT355554B (de) 1980-03-10
DE2738589A1 (de) 1978-03-02
NO144793C (no) 1981-11-11
FI772551A7 (fi) 1978-02-28
BE858134A (fr) 1977-12-16
DK150196B (da) 1987-01-05
DD132433A5 (de) 1978-09-27
FI68396C (fi) 1985-09-10
JPS5350131A (en) 1978-05-08
DK150196C (da) 1987-07-06
CA1077506A (en) 1980-05-13

Similar Documents

Publication Publication Date Title
US3966749A (en) Novel synthesis of optically active m-acyloxy-α-[(methylamino)methyl]benzyl alcohols, the pharmaceutically acceptable acid addition salts thereof and intermediate useful in the preparation thereof
US4187220A (en) New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
KR0154117B1 (ko) 0-(3-아미노-2-히드록시프로필) 히드록심산할라이드 및 그의 제조방법
HU177578B (en) Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives
US3522319A (en) Phenol substituted tetrahydronaphthalenes useful as estrogenics
PL117997B1 (en) Process for preparing novel,optically active phenethanoloamineslaminov
NO166557B (no) Innretning for omstabling av en bladstabel.
EP0047536B1 (en) Substituted propylamines
CS229940B2 (en) Production method substiuted pyridazine derivatives
US4308399A (en) O-(3-Amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
NO161543B (no) Sprengladning for bruk ved skjoeting av roer ved eksplosjonssveising.
PL90322B1 (en, 2012)
US2485550A (en) Quaternary salts of carbamic acid esters of tertiary-hydroxybenzyl-amines
JP3606326B2 (ja) 欝病、不安神経症およびパーキンソン病を治療するための１−アリールシクロアルキルスルフィド、スルホキシドおよびスルホン
CS214696B2 (en) Method of making the 9-aminoalcylfluorenes
DE2450617C2 (de) Phenylalkancarbonsäure-Derivate, ihre Salze, Verfahren zu ihrer Herstellung und Arzneimittel
FI78682C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara oximetrar.
CY1221A (en) Secondary amino tetrazolyloxypropanols
GB2051796A (en) (3 - alkylamino - 2 - hydroxypropoxy)-furan - 2 - carboxylic acid anilides and physiologically tolerated acid addition salts thereof processes for their preparation and medicaments containing them
US2927132A (en) 1-(4-amino-2-alkoxyphenoxy)-benzamidoalkanes
EP1644328A1 (en) Sulfonamide derivatives as 5ht7 receptor antagonists
IE48442B1 (en) Imidazolylethyl ether derivatives of pyrazolo(3,4-b)pyridine-5-methanols
US3850947A (en) 3-thiazol-4'-oxy-aminopropanol cardiovascular agents
US3407234A (en) 4-(2-benzylalkylaminoalkoxy)-benzylamines
US4259257A (en) 1-Phenyl-2-amino-1,3-propanediol-N-aryloxyalkyl derivatives

Legal Events

Date Code Title Description
HU90 Patent valid on 900628